U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721961) titled 'A Study of MI078 for Postpartum Depression' on July 10.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled trial consisting of an experimental drug group and a placebo group, each enrolling 100 participants. The objective of this study is to assess the efficacy and safety of MI078 capsules for the treatment of postpartum depression.

Study Start Date: July 10

Study Type: INTERVENTIONAL

Condition: Postpartum Depression (PPD)

Intervention: DRUG: MI078 capsule

MI078 capsule for 3 days

DRUG: Placebo of MI078 capsules

Placebo for 3days

Recruitment Status: RECRUITING

Sponsor: Nanjing Minova Pharma...